JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.1782iti1
The Journal of Cell Biology, Vol. 178, No. 2, 181-
The Rockefeller University Press, 0021-9525 $30.00
© Leslie
This Article
Right arrow Full Text (PDF, 645K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leslie, M.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

Caspase-free mitotic death



Figure 1
DNA (blue) breaks up as a cell with a faulty spindle checkpoint prepares to kill itself.

On page 283, Niikura et al. document a new way for abnormal cells to kill themselves. The mechanism might weed out potentially cancerous cells in which the spindle checkpoint has malfunctioned.

Before progressing through mitosis, cells verify that the microtubules of the spindle apparatus are properly attached to the chromosomes. If they aren't, the spindle checkpoint kicks in, halting mitosis to permit repairs. If the spindle checkpoint goes awry, cells can amass extra chromosomes and become cancerous. Apoptosis disposes of many of these aneuploid cells during the next G1 phase. Niikura et al. wanted to find out whether spindle checkpoint defects can also trigger cells to die during mitosis.

The researchers used RNAi to cut cells' output of the checkpoint protein BUB1. Three drugs that disrupt the kinetochore–microtubule connection spurred these cells to expire during mitosis. Like victims of apoptosis, BUB1-deficient cells harbored fractured DNA. However, their demise didn't involve caspase enyzymes, suggesting that this type of cell suicide—which the researchers dubbed caspase-independent mitotic death (CIMD)—is distinct from apoptosis. CIMD doesn't depend on p53, which prompts cells with DNA damage to take their own lives, but does require its cousin p73. The results indicate that cells have a mitotic self-elimination mechanism in case the spindle checkpoint falters. Some details of CIMD remain mysterious, however. For example, the researchers are now investigating why CIMD can occur if BUB1 levels are low, but not if the protein is altogether absent. Formula



Mitch Leslie

mitchleslie{at}comcast.net


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

BUB1 mediation of caspase-independent mitotic death determines cell fate
Yohei Niikura, Amruta Dixit, Ray Scott, Guy Perkins, and Katsumi Kitagawa
J. Cell Biol. 2007 178: 283-296. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 645K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leslie, M.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents